296 related articles for article (PubMed ID: 11834884)
1. Non-paralleled increase of hepatocyte growth factor and vascular endothelial growth factor in the eyes with angiogenic and nonangiogenic fibroproliferation.
Umeda N; Ozaki H; Hayashi H; Kondo H; Uchida H; Oshima K
Ophthalmic Res; 2002; 34(1):43-7. PubMed ID: 11834884
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders.
Katsura Y; Okano T; Noritake M; Kosano H; Nishigori H; Kado S; Matsuoka T
Diabetes Care; 1998 Oct; 21(10):1759-63. PubMed ID: 9773744
[TBL] [Abstract][Full Text] [Related]
3. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
[TBL] [Abstract][Full Text] [Related]
4. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
[TBL] [Abstract][Full Text] [Related]
5. Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy.
Shinoda K; Ishida S; Kawashima S; Wakabayashi T; Uchita M; Matsuzaki T; Takayama M; Shinmura K; Yamada M
Curr Eye Res; 2000 Aug; 21(2):655-61. PubMed ID: 11148602
[TBL] [Abstract][Full Text] [Related]
6. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy.
Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M
Am J Ophthalmol; 2002 Sep; 134(3):348-53. PubMed ID: 12208245
[TBL] [Abstract][Full Text] [Related]
7. Vitreous concentrations of TPA and plasminogen activator inhibitor are associated with VEGF in proliferative diabetic vitreoretinopathy.
Hattenbach LO; Allers A; Gümbel HO; Scharrer I; Koch FH
Retina; 1999; 19(5):383-9. PubMed ID: 10546932
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
[TBL] [Abstract][Full Text] [Related]
9. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
10. Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin.
Noma H; Funatsu H; Yamashita H; Kitano S; Mishima HK; Hori S
Arch Ophthalmol; 2002 Aug; 120(8):1075-80. PubMed ID: 12149062
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy.
Hernández C; Lecube A; Segura RM; Sararols L; Simó R
Diabet Med; 2002 Aug; 19(8):655-60. PubMed ID: 12147146
[TBL] [Abstract][Full Text] [Related]
12. [A comparative study of vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy].
Zhou H; Zhang H
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):247-50. PubMed ID: 10451953
[TBL] [Abstract][Full Text] [Related]
13. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
14. Increased vitreous concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy.
Nishimura M; Ikeda T; Ushiyama M; Nanbu A; Kinoshita S; Yoshimura M
J Clin Endocrinol Metab; 1999 Feb; 84(2):659-62. PubMed ID: 10022434
[TBL] [Abstract][Full Text] [Related]
15. Elevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
Deng J; Wu DZ; Gao R
Yan Ke Xue Bao; 1999 Mar; 15(1):17-21. PubMed ID: 12579655
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus.
Shinoda K; Ishida S; Kawashima S; Wakabayashi T; Matsuzaki T; Takayama M; Shinmura K; Yamada M
Br J Ophthalmol; 1999 Jul; 83(7):834-7. PubMed ID: 10381671
[TBL] [Abstract][Full Text] [Related]
17. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
[TBL] [Abstract][Full Text] [Related]
18. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy.
Mohan N; Monickaraj F; Balasubramanyam M; Rema M; Mohan V
J Diabetes Complications; 2012; 26(5):435-41. PubMed ID: 22699109
[TBL] [Abstract][Full Text] [Related]
19. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
Funatsu H; Yamashita H; Nakanishi Y; Hori S
Br J Ophthalmol; 2002 Mar; 86(3):311-5. PubMed ID: 11864890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
